Amedica introduced the Valeo II™ C interbody fusion system in advance of its mid-1Q16 launch.
The next-generation design features a slim profile to support intraoperative visibility, directional teeth to resist expulsion and a 14x12mm footprint for smaller patients. Further, the revised implants come with new consolidated, single-level instrumentation sets with improved ergonomics.
Source: Amedica Corporation
The Valeo C line is reportedly the first to receive FDA clearance for 2-level cervical interbody cage indications, as announced in 2Q15.